Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?

European Journal of Cancer

Volumn 55, Issue , 2016, Pages 47-55

  Barbaric, Jelena ^a   Sekerija, Mario ^b   Agius, Dominic ^c   Coza, Daniela ^d   Dimitrova, Nadya ^e   Demetriou, Anna ^f   Safaei Diba, Chakameh ^g   Eser, Sultan ^h,i   Gavric, Zivana ^j   Primic Zakelj, Maja ^k   Zivkovic, Snezana ^l   Zvolsky, Miroslav ^m   Bray, Freddie ⁿ   Coebergh, Jan Willem ^o   Znaor, Ariana ⁿ  

^a Agency for Quality and Accreditation in Health   (Croatia)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c Malta National Cancer Registry   (Malta)

^d THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^e National Oncology Center Bulgaria   (Bulgaria)

^f NICOSIA GENERAL HOSPITAL   (Cyprus)

^g CANCER RESEARCH INSTITUTE   (Slovakia)

^h HACETTEPE UNIVERSITY   (Turkey)

ⁱ Izmir Public Health Directorate   (Turkey)

^j Public Health Institute Banja Luka   (Bosnia and Herzegovina)

^k INSTITUTE OF ONCOLOGY   (Slovenia)

^l Institute of Public Health of Serbia   (Serbia)

^m Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

ⁿ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^o ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Incidence; Malignant melanoma; Mortality; South Eastern Europe; Trends

Indexed keywords

ADULT; AGED; ARTICLE; BOSNIA AND HERZEGOVINA; BULGARIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; COMPARATIVE STUDY; CROATIA; CYPRUS; CZECH REPUBLIC; EASTERN EUROPE; FEMALE; GROUPS BY AGE; HEALTH DISPARITY; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MALTA; MELANOMA; MIDDLE AGED; MORTALITY RATE; PRIORITY JOURNAL; ROMANIA; SERBIA; SLOVAKIA; SLOVENIA; TREND STUDY; TURKEY (REPUBLIC); AGE DISTRIBUTION; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; EUROPE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; INCIDENCE; MORTALITY; MULTICENTER STUDY; REGISTER; RISK FACTOR; SEX RATIO; SKIN NEOPLASMS; TIME FACTOR; TRENDS;

ADULT; AGE DISTRIBUTION; AGED; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MORTALITY; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; TIME FACTORS;

EID: 84953858132     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.11.019     Document Type: Article

References (43)

1. D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Piñeros, and et al. Cancer incidence in five continents, vol. X 2013 Lyon
2. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, D. Abeni, P. Boyle, and et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi Eur J Cancer 41 1 2005 28 44
3. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, O. Picconi, P. Boyle, and et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure Eur J Cancer 41 1 2005 45 60
4. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, R. Zanetti, C. Masini, and et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors Eur J Cancer 41 14 2005 2040 2059
5. A. Joosse, S. Collette, S. Suciu, T. Nijsten, P.M. Patel, U. Keilholz, and et al. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials J Clin Oncol 31 18 2013 2337 2346
6. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, and et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 5 2015 E359 E386
7. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, and et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 2013 [Internet]
8. F. Erdmann, J. Lortet-Tieulent, J. Schüz, H. Zeeb, R. Greinert, E.W. Breitbart, and et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 132 2 2013 385 400
9. E. De Vries, F.I. Bray, J.W.W. Coebergh, and D.M. Parkin Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia Int J Cancer 107 1 2003 119 126
10. A. Znaor, C. van den Hurk, M. Primic-Zakelj, D. Agius, D. Coza, A. Demetriou, and et al. Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe Eur J Cancer 49 7 2013 1683 1691
11. European Parliament resolution of 10th April 2008 on combating cancer in the enlarged European Union (2009/C 247 E/04). Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.CE.2009.247.01.0011.01.ENG [accessed 23.06.14].
12. Treaty establishing the European Community (Amsterdam consolidated version) Part Three: Community policies. Title XIII: Public health. Article 152. Available from: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:11997E152 [accessed 09.03.15].
13. European Commission website. Available from: http://ec.europa.eu/enlargement/countries/check-current-status/index-en.htm [accessed 14.04.14].
14. J. Barbarić, and A. Znaor Incidence and mortality trends of melanoma in Croatia Croat Med J 53 2 2012 135 140
15. A.M. Forsea, V. Del Marmol, E. de Vries, E.E. Bailey, and A.C. Geller Melanoma incidence and mortality in Europe: new estimates, persistent disparities Br J Dermatol 167 5 2012 1124 1130
16. EUROCOURSE Project website. Available from: http://www.eurocourse.org/ [accessed 14.04.14].
17. S. Siesling, W.J. Louwman, A. Kwast, C. van den Hurk, M. O'Callaghan, S. Rosso, and et al. Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012 Eur J Cancer 51 9 2015 1039 1049
18. Joinpoint Regression Program, Version 4.0.4 Statistical Methodology and Applications Branch, Surveillance Research Program May 2013 National Cancer Institute
19. H.J. Kim, M.P. Fay, and E.J.M.D. Feuer Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 3 2000 335 351 (correction 2001;20(4):655)
20. Hammarström H, Forkel R, Haspelmath M, Bank S. Glottolog 2.4. Leipzig: Max Planck Institute for Evolutionary Anthropology. Available from: http://glottolog.org [accessed 06.10.14].
21. The UN World Tourism Organization (UNWTO) Data provided on request through personal communication October 24, 2014 Available from: http://www.e-unwto.org/content/v486k6/?v=search
22. A. Stratigos, A.M. Forsea, R.J.T. van der Leest, E. de Vries, E. Nagore, J.-L. Bulliard, and et al. Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future Br J Dermatol 167 Suppl. 2 2012 99 104
23. E. Crocetti, S. Mallone, T.E. Robsahm, A. Gavin, D. Agius, E. Ardanaz, and et al. Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study Eur J Cancer 2015 10.1016/j.ejca.2015.07.039 pii: S0959-8049(15)00745-5 [Epub ahead of print]
24. World Bank 2010. Available from: http://data.worldbank.org/indicator/SH.XPD.PCAP/countries [accessed 6.10.14].
25. E. De Vries, M. Boniol, J.F. Doré, J.W. Coebergh EUROCARE working group Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe Eur J Cancer 40 7 2004 1045 1052
26. M. Arnold, C. Holterhues, L.M. Hollestein, J.W.W. Coebergh, T. Nijsten, E. Pukkala, and et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015 J Eur Acad Dermatol Venereol 28 9 2014 1170 1178
27. C. Bosetti, P. Bertuccio, M. Malvezzi, F. Levi, L. Chatenoud, E. Negri, and et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980 Ann Oncol 24 10 2013 2657 2671
28. P. Autier, A. Koechlin, and M. Boniol The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations Eur J Cancer 51 7 2015 869 878
29. T. Fitzpatrick The validity and practicality of sun-reactive skin types I through VI Arch Dermatol 124 6 1988 869 871
30. EUROSUN project website. Available from: http://www.eurosun-project.org/ [accessed 23.06.14].
31. R.J.T. Van der Leest, E. de Vries, J.-L. Bulliard, J. Paoli, K. Peris, A.J. Stratigos, and et al. The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010 J Eur Acad Dermatol Venereol 25 12 2011 1455 1465
32. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, et al. EUROCARE-5 Working Group Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study Lancet Oncol 15 1 2014 23 34
33. M. Primic-Zakelj, V. Zadnik, and T. Zagar Epidemiologija kožnega raka (Epidemiology of skin cancer, in Slovenian) B. Luzar, Novosti v dermatopatologiji (Update on dermatopathology, in Slovenian) Proceedings of XL. memorialni sestanek profesorja Janeza Plečnika, Ljubljana 3-4 December 2009 2009 Ljubljani Inštitut za Patol. Med. Fak. [COBISS.SI-ID 26570201]
34. H.G. Welch, S. Woloshin, and L.M. Schwartz Skin biopsy rates and incidence of melanoma: population based ecological study BMJ 331 2005 481
35. R.J.T. Van der Leest, J. Zoutendijk, T. Nijsten, W. Mooi, J. van der Rhee, E. de Vries, and et al. Increasing time trends of thin melanomas in The Netherlands: what are the explanations of recent accelerations? Eur J Cancer 51 18 2015 2833 2841
36. M.P. Curado, B. Edwards, H.R. Shin, H. Storm, J. Ferlay, M. Heanue, and et al. Cancer incidence in five continents, vol. IX 2007 Lyon
37. R. Zanetti, F. Sera, L. Sacchetto, J.W. Coebergh, and S. Rosso Power analysis to detect time trends on population-based cancer registries data: when size really matters Eur J Cancer 51 9 2015 1082 1090
38. A.M.M. Eggermont, and C. Robert Melanoma: smart therapeutic strategies in immuno-oncology Nat Rev Clin Oncol 11 4 2014 181 182
39. A.M.M. Eggermont, A. Spatz, and C. Robert Cutaneous melanoma Lancet 383 9919 2014 816 827
40. D. Schadendorf, F.S. Hodi, C. Robert, J.S. Weber, K. Margolin, O. Hamid, and et al. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma J Clin Oncol 33 17 2015 1889 1894
41. K.G. Griewank, R.A. Scolyer, J.F. Thompson, K.T. Flaherty, D. Schadendorf, and R. Murali Genetic alterations and personalized medicine in melanoma: progress and future prospects J Natl Cancer Inst 106 2 2014 djt435
42. C. Robert, B. Karaszewska, J. Schachter, P. Rutkowski, A. Mackiewicz, D. Stroiakovski, and et al. Improved overall survival in melanoma with combined dabrafenib and trametinib N Engl J Med 372 1 2015 30 39
43. A. Micheli, R. Ciampichini, W. Oberaigner, L. Ciccolallo, E. de Vries, I. Izarzugaza, et al. EUROCARE Working Group The advantage of women in cancer survival: an analysis of EUROCARE-4 data Eur J Cancer 45 6 2009 1017 1027